IRVINGTON, N.Y. (AP) – Prestige Brands Holdings Inc. said that it posted a $15,000 fiscal fourth-quarter loss on the costs of acquiring 17 healthcare brands from GlaxoSmithKline plc.
On a per-share basis, the Irvington, N.Y., company’s results were break-even for the three months ended March 31. That compares with profit of $6.4 million, or 13 cents per share, a year ago.
Excluding charges related to the $660 million acquisition from Glaxo, and other items, the seller of over-the-counter drugs and household cleaning products said it posted an adjusted profit of 26 cents per share for the recent quarter.
Analysts, on average, expected a profit of 23 cents per share, according to a FactSet poll.
With two months of contributions from its recently acquired brands, Prestige’s revenue jumped 39% to $134 million from $96.4 million. Analysts expected $130.2 million. Excluding the 17 brands, revenue rose 7.5%.
For the full fiscal year 2012, Prestige earned $37.2 million, or 73 cents per share, up from $29.2 million, or 58 cents per share, in fiscal 2011. Revenue rose 31% to $441.1 million from $336.5 million.
The company said it still expects to post an adjusted fiscal 2013 profit of $1.22 to $1.32 per share, while analysts polled by FactSet expect a profit of $1.26 per share.
Date: May 17, 2012
Source: Associated Press
